PAPAGNA ANGELA MARIA

Role: 
Research fellow
Academic disciplines: 
EXPERIMENTAL MEDICINE AND PATHOPHYSIOLOGY (MED/04)

Publications

  • Van Acker, H., Beretta, O., Anguille, S., Caluwé, L., Papagna, A., Van den Bergh, J., et al. (2017). Desirable cytolytic immune effector cell recruitment by interleukin-15 dendritic cells. ONCOTARGET, 8(8), 13652-13665.
  • Ripamonti, C., Papagna, A., Storini, C., Miglietta, D., & Foti, M. (2017). NO donors exhibit anti-inflammatory properties by modulating inflammatory signatures and by regulating the life cycle of dendritic cells. JOURNAL OF LEUKOCYTE BIOLOGY, 102(6), 1421-1430.
  • Piermattei, A., Migliara, G., Di Sante, G., Foti, M., Hayrabedyan, S., Papagna, A., et al. (2016). Toll-like receptor 2 mediates in vivo pro- and anti-inflammatory effects of Mycobacterium Tuberculosis and modulates autoimmune encephalomyelitis. FRONTIERS IN IMMUNOLOGY, 7(MAY).
  • Fumagalli, S., Torri, A., Papagna, A., Citterio, S., Mainoldi, F., & Foti, M. (2016). IL-22 is rapidly induced by Pathogen Recognition Receptors Stimulation in Bone-Marrow-derived Dendritic Cells in the Absence of IL-23. SCIENTIFIC REPORTS, 6.
  • Colleoni, L., Kapetis, D., Franzi, S., Canioni, E., Biancolini, D., Papagna, A., et al. (2013). Identification of predictive biomarkers for azathioprine treatment: a pharmacogenomics study on myastenia gravis therapy. Intervento presentato a: MYASTHENIA 2013J, Paris, France.